Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-Methyl-N′-[2-methyl-5-[[[1-methyl-3-(pyridin-4-yl)-1H-indazol-5-yl]carbonyl]amino]phenyl]terephthalamide showed weak affinity for BRDT-BD1 with IC50 values <10 μM.
Description | N-Methyl-N′-[2-methyl-5-[[[1-methyl-3-(pyridin-4-yl)-1H-indazol-5-yl]carbonyl]amino]phenyl]terephthalamide showed weak affinity for BRDT-BD1 with IC50 values >10 μM. |
Molecular Weight | 518.57 |
Formula | C30H26N6O3 |
CAS No. | 2757619-87-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-Methyl-N′-[2-methyl-5-[[[1-methyl-3-(pyridin-4-yl)-1H-indazol-5-yl]carbonyl]amino]phenyl]terephthalamide 2757619-87-5 inhibitor inhibit